Ann: Final Evidence Package Submitted to Health Canada - Updated, page-18

You may recall that Aphria (Where Greg Battersby used to work and is coincidentally the owner of Peak Processing) was accused of buying "overpriced private companies" to divert listed company money to non-arms length directors:

Aphria was accused of having made some purchases of value-inflated international assets to allegedly divert shareholders money to the directors. I have attached some news paper articles but you can google many more.

Why would Althea raise $30m to buy 46% of an international asset they don't have control of that's in a foreign land and is only 4000sqm in full size?

That's a massive price and also it's a massive risk with delegated control to a third party who have no alignment with Althea?

I would curious to know what people think about this?